"Navigating the Modern News Zoo so you don't have to."
Friday, May 23, 2025
New combination therapy found safe and feasible for neuroendocrine tumor patients
A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been deemed feasible and tolerable for neuroendocrine cancer patients. The combined therapy works by preventing cancer cells from repairing themselves after targeted treatment and has the potential to help patients achieve longer-lasting disease control. This research was published in the May issue of The Journal of Nuclear Medicine.
š Full Story
If she believes in the word of God, then why is she even a "Pastor"? #shorts
- X is experiencing a data center outage - Ian Carlos Campbell
- Screwworms are comingāand theyāre just as horrifying as they sound - Beth Mole
- How Shakespeare Made Picard A Better Star Trek Captain - Chris Snellgrove
- Are You a Good Driver? Sharing Data on Your Driving Could Lower Your Car Insurance Rates
- YRKKH Written Update 11 August 2024: Abhira Refuses to Marry Arman as Ruhiās Plan Unfolds! - Aaradhana Chaurasia
- Open social web browser Surf makes it easier for anyone to build custom feeds - Sarah Perez
Android Gets A Major Change!
- Time Magazine appears to accidentally publish embargoed story confirming new Anthropic model - Carl Franzen
- Vibrating capsule shown to be safe, tolerable in treating chronic idiopathic constipation
- The complete Side Events lineup at TechCrunch Sessions: AI - TechCrunch Events
- Wildlife Studios signs Naomi Osaka and other stars for Tennis Clash - Dean Takahashi
- A Complete Guide to the Benefits and Uses of Vitamin D3 - Kirstyn Hill, PharmD, MPH
- Coffee vs. Matcha: Which Oneās Actually Better for Your Health? - Isabel Vasquez RD LDN
